Nasdaq · CIK 0001360214
HROW HARROW, INC.
Insider trading from SEC Form 4. Last filing Dec 16, 2025. Close $29.36 on Oct 9, 2026, +1% from the 52-week low and -46% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
HROWOct 9, 2026 · close 29.36
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at HARROW, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Opaleye Management Inc. owner sell | $924k 30,204 shares | -25% | +36% from low-48% from high | |
| 23Weak | Opaleye Management Inc. owner sell | $144k 4,796 shares | -4% | +32% from low-49% from high | |
| 33Weak | Opaleye Management Inc. owner sell | $392k 15,000 shares | -11% | +20% from low-54% from high | |
| 23Weak | Opaleye Management Inc. owner sell | $150k 5,000 shares | -3% | +35% from low-48% from high | |
| 23Weak | Opaleye Management Inc. owner sell | $148k 5,000 shares | -3% | +21% from low-53% from high | |
| 23Weak | Opaleye Management Inc. owner sell | $150k 5,000 shares | -3% | +21% from low-53% from high | |
| 23Weak | Opaleye Management Inc. owner sell | $148k 5,000 shares | -3% | +21% from low-53% from high | |
| 23Weak | Opaleye Management Inc. owner sell | $140k 5,000 shares | -3% | - | |
| 38Weak | Opaleye Management Inc. owner sell | $712k 20,000 shares | -11% | - |
Transactions
The last 37 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Andrew R. Boll PRESIDENT AND CFO | MOption exercise Common Stock | +60,000 | $3.95 | $237k | 837,844 | Dec 16, 2025 |
| Dec 12, 2025 | Mark L Baum CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +180,000 | $3.95 | $711k | 3,066,124 | Dec 16, 2025 |
| Dec 12, 2025 | Mark L Baum CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -79,994 | $47.06 | $3.8M | 2,986,130 | Dec 16, 2025 |
| Dec 12, 2025 | Andrew R. Boll PRESIDENT AND CFO | FTax withholding Common Stock | -26,665 | $47.06 | $1.3M | 811,179 | Dec 16, 2025 |
| Dec 12, 2025 | Mark L Baum CHIEF EXECUTIVE OFFICER | MOption exercise Stock Option (Right to Buy)derivative | -180,000 | $0.00 | $0 | 0 | Dec 16, 2025 |
| Dec 12, 2025 | Andrew R. Boll PRESIDENT AND CFO | MOption exercise Stock Option (Right to Buy)derivative | -60,000 | $0.00 | $0 | 0 | Dec 16, 2025 |
| Sep 1, 2025 | Randall E. Pollard CHIEF ACCOUNTING OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Sep 9, 2025 |
| Jul 21, 2025 | Mark L Baum CHIEF EXECUTIVE OFFICER | MOption exercise Common stock | +600,000 | $7.87 | $4.7M | 3,199,462 | Jul 23, 2025 |
| Jul 21, 2025 | Mark L Baum CHIEF EXECUTIVE OFFICER | FTax withholding Common stock | -313,338 | $37.08 | $12M | 2,886,124 | Jul 23, 2025 |
| Jul 31, 2015 | Mark L Baum CHIEF EXECUTIVE OFFICER | MOption exercise Stock Option (Right to Buy)derivative | -600,000 | $0.00 | $0 | 0 | Jul 23, 2025 |
| Jul 1, 2025 | Andrew R. Boll CHIEF FINANCIAL OFFICER | AGrant or award RSUderivative | +405,750 | $0.00 | $0 | 405,750 | Jul 1, 2025 |
| Jul 1, 2025 | Mark L Baum CHIEF EXECUTIVE OFFICER | AGrant or award RSUderivative | +889,500 | $0.00 | $0 | 889,500 | Jul 1, 2025 |
| Jun 20, 2025 | Adrienne L Graves director | AGrant or award RSUderivative | +7,339 | $0.00 | $0 | 7,339 | Jun 24, 2025 |
| Jun 20, 2025 | Perry J. Sternberg director | AGrant or award RSUderivative | +7,339 | $0.00 | $0 | 7,339 | Jun 24, 2025 |
| Jun 20, 2025 | Lauren P Silvernail director | AGrant or award RSUderivative | +7,339 | $0.00 | $0 | 7,339 | Jun 24, 2025 |
| Jun 9, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -15,204 | $30.37 | $462k | 105,000 | Jun 11, 2025 |
| Jun 10, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -15,000 | $30.80 | $462k | 90,000 | Jun 11, 2025 |
| Jun 3, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -3,000 | $30.04 | $90k | 122,000 | Jun 5, 2025 |
| Jun 4, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -1,796 | $30.02 | $54k | 120,204 | Jun 5, 2025 |
| May 12, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -10,000 | $25.90 | $259k | 130,000 | May 14, 2025 |
| Mar 18, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -5,000 | $29.64 | $148k | 145,000 | May 14, 2025 |
| Mar 24, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -5,000 | $30.01 | $150k | 140,000 | May 14, 2025 |
| May 13, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -5,000 | $26.59 | $133k | 125,000 | May 14, 2025 |
| Apr 3, 2025 | Mark L Baum Chief Executive Officer | MOption exercise Common Stock | +762,300 | $0.00 | $0 | 2,899,825 | Apr 7, 2025 |
| Apr 3, 2025 | Andrew R. Boll Chief Financial Officer | MOption exercise Common Stock | +346,500 | $0.00 | $0 | 914,589 | Apr 7, 2025 |
| Apr 3, 2025 | John P. Saharek CEO & President, ImprimisRx | MOption exercise Common Stock | +277,200 | $0.00 | $0 | 576,863 | Apr 7, 2025 |
| Apr 7, 2025 | John P. Saharek CEO & President, ImprimisRx | FTax withholding Common Stock | -109,475 | $23.09 | $2.5M | 467,388 | Apr 7, 2025 |
| Apr 7, 2025 | Andrew R. Boll Chief Financial Officer | FTax withholding Common Stock | -136,745 | $23.09 | $3.2M | 777,844 | Apr 7, 2025 |
| Apr 7, 2025 | Mark L Baum Chief Executive Officer | FTax withholding Common Stock | -300,363 | $23.09 | $6.9M | 2,599,462 | Apr 7, 2025 |
| Apr 3, 2025 | Mark L Baum Chief Executive Officer | MOption exercise Performance Stock Unitderivative | -762,300 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Apr 3, 2025 | Andrew R. Boll Chief Financial Officer | MOption exercise Performance Stock Unitderivative | -346,500 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Apr 3, 2025 | John P. Saharek CEO & President, ImprimisRx | MOption exercise Performance Stock Unitderivative | -277,200 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Mar 18, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -5,000 | $30.01 | $150k | 140,000 | Mar 26, 2025 |
| Mar 18, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -5,000 | $29.64 | $148k | 145,000 | Mar 20, 2025 |
| Feb 28, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -5,000 | $28.05 | $140k | 150,000 | Mar 4, 2025 |
| Jan 22, 2025 | Opaleye Management Inc. owner | SOpen-market sale Common Stock, par value $0.001 per shareindirect: By Managed Account | -20,000 | $35.59 | $712k | 155,000 | Jan 24, 2025 |
| Jan 6, 2025 | Amir Shojaei CHIEF SCIENTIFIC OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jan 8, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Mark L BaumCHIEF EXECUTIVE OFFICER
- Andrew R. BollPRESIDENT AND CFO
- Adrienne L Gravesdirector
- Opaleye Management Inc.owner
- Randall E. PollardCHIEF ACCOUNTING OFFICER
- John P. SaharekCEO & President, ImprimisRx
- Lauren P Silvernaildirector
- Amir ShojaeiCHIEF SCIENTIFIC OFFICER
- Perry J. Sternbergdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.